Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    16490414 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
Conditions: Obsessive-compulsive Disorder;   Ocd
Interventions: Drug: riluzole;   Drug: placebo
2 Terminated
Has Results
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: N-Acetylcysteine;   Drug: placebo
3 Completed Antibiotic Treatment Trial for the PANDAS/PANS Phenotype
Conditions: PANS;   PANDAS;   Obsessive Compulsive Disorder (OCD)
Interventions: Drug: Azithromycin;   Drug: Placebo
4 Terminated
Has Results
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
Conditions: Borderline Personality Disorder;   Self-Injurious Behavior
Interventions: Drug: N-Acetylcysteine;   Drug: placebo

Indicates status has not been verified in more than two years